Tower Research Capital (TRC)’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41
| Closed | -$47 | – | 5936 |
|
|
2024
Q4 | $47 | Hold |
41
| – | – | ﹤0.01% | 5549 |
|
|
2024
Q3 | $57 | Hold |
41
| – | – | ﹤0.01% | 5558 |
|
|
2024
Q2 | $466 | Hold |
41
| – | – | ﹤0.01% | 5321 |
|
|
2024
Q1 | $453 | Sell |
41
-34
| -45% | -$376 | ﹤0.01% | 5484 |
|
|
2023
Q4 | $820 | Sell |
75
-5
| -6% | -$55 | ﹤0.01% | 5491 |
|
|
2023
Q3 | $862 | Sell |
80
-4
| -5% | -$43 | ﹤0.01% | 5455 |
|
|
2023
Q2 | $885 | Buy |
+84
| New | +$885 | ﹤0.01% | 5499 |
|